Skip to content
PeptiLab
Research goal

Fat Loss

GLP-1/GIP agonists and metabolic peptides researched for their effect on appetite signalling, glucose regulation and body composition.

Products

Retatrutide 10 mg
Metabolic

Retatrutide

Retatrutide · 10 mg

Lilly's next-generation triple agonist: GIP, GLP-1 and glucagon in one molecule.

Rp 2.690.000≈ $152In stock
Tirzepatide 20 mg
Metabolic

Tirzepatide

Tirzepatide · 20 mg

The dual GIP/GLP-1 agonist behind the landmark SURMOUNT trials.

Rp 3.690.000≈ $209In stock
MOTS-c 10 mg
Metabolic

MOTS-c

MOTS-c · 10 mg

The mitochondrial exercise peptide discovered at USC.

Rp 1.190.000≈ $67In stock

Recommended stack

The Metabolic Stack
PeptiLab Tirzepatide 20 mg pen
PeptiLab MOTS-c 10 mg pen
TirzepatideMOTS-c
Fat Loss

The Metabolic Stack

Tirzepatide and MOTS-c: intake and energy use, both sides of metabolism.

Rp 4.940.000≈ $280Rp 6.180.000−20%

Save Rp 1.240.000 vs buying separately

Ships as 2 pens: Tirzepatide, MOTS-c

Research on fat loss

Tirzepatide and Retatrutide: What Separates a Dual Agonist from a Triple

One targets two receptors, the other three. The published trials show what that difference has and has not been shown to buy.

For research use only. Not for human consumption, medical treatment, or veterinary use. Full disclaimer